Revvity (NYSE:RVTY – Free Report) had its price target increased by JPMorgan Chase & Co. from $160.00 to $165.00 in a research report sent to investors on Monday,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock.
RVTY has been the subject of several other reports. UBS Group started coverage on Revvity in a research report on Wednesday, September 9th. They set a “neutral” rating and a $140.00 price target for the company. Royal Bank Of Canada upped their price objective on Revvity from $135.00 to $172.00 and gave the stock a “sector perform” rating in a research report on Wednesday, November 4th. Zacks Research raised shares of Revvity from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 4th. Cfra raised shares of Revvity from a “hold” rating to a “buy” rating in a report on Wednesday, November 4th. Finally, Sanford C. Bernstein reiterated a “market perform” rating on shares of Revvity in a research note on Thursday, November 12th. Six analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $136.71.
Check Out Our Latest Research Report on RVTY
Revvity Price Performance
Shares of NYSE RVTY opened at $152.57 on Monday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.10 and a current ratio of 2.65. The company has a market cap of $17.03 billion, a PE ratio of 26.63, a P/E/G ratio of 2.56 and a beta of 1.08. The business has a 50-day simple moving average of $151.83 and a two-hundred day simple moving average of $114.90. Revvity has a fifty-two week low of $81.22 and a fifty-two week high of $171.74.
Revvity (NYSE:RVTY – Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $1.38 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.08. Revvity had a return on equity of 8.64% and a net margin of 8.61%. The business had revenue of $728.90 million for the quarter, compared to the consensus estimate of $694.73 million. During the same quarter in the previous year, the business earned $1.18 EPS. The company’s quarterly revenue was up 4.3% compared to the same quarter last year. As a group, equities analysts expect that Revvity will post 5.42 EPS for the current fiscal year.
Revvity Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 12th. Stockholders of record on Friday, January 22nd will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, January 22nd. Revvity’s dividend payout ratio is 12.39%.
Insider Transactions at Revvity
In other Revvity news, insider Maxwell Krakowiak sold 1,631 shares of Revvity stock in a transaction dated Monday, September 21st. The shares were sold at an average price of $144.53, for a total transaction of $235,728.43. Following the transaction, the insider directly owned 14,781 shares of the company’s stock, valued at $2,136,297.93. The trade was a 9.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Tajinder S. Vohra sold 7,330 shares of the stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $140.88, for a total transaction of $1,032,650.40. Following the completion of the sale, the insider directly owned 6,635 shares of the company’s stock, valued at approximately $934,738.80. This trade represents a 52.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 9,045 shares of company stock valued at $1,281,439. 0.85% of the stock is owned by insiders.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of RVTY. Apollon Wealth Management LLC boosted its holdings in shares of Revvity by 2.7% in the 3rd quarter. Apollon Wealth Management LLC now owns 2,778 shares of the company’s stock worth $425,000 after purchasing an additional 73 shares in the last quarter. Moors & Cabot Inc. grew its holdings in shares of Revvity by 3.1% in the third quarter. Moors & Cabot Inc. now owns 2,448 shares of the company’s stock worth $374,000 after purchasing an additional 73 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its position in shares of Revvity by 5.4% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,074 shares of the company’s stock valued at $231,000 after acquiring an additional 106 shares during the period. EverSource Wealth Advisors LLC increased its holdings in Revvity by 17.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock valued at $66,000 after purchasing an additional 109 shares during the period. Finally, Angeles Wealth Management LLC raised its holdings in shares of Revvity by 2.0% during the second quarter. Angeles Wealth Management LLC now owns 5,804 shares of the company’s stock valued at $646,000 after acquiring an additional 112 shares in the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.
About Revvity
Revvity, Inc. develops and supplies products and services for life sciences research and clinical diagnostics. Its offerings include instruments, reagents, software and related services used by pharmaceutical and biotechnology companies, academic and government research institutions, hospitals and clinical laboratories. The company’s work spans areas such as drug discovery and development, genetic testing, newborn screening and other diagnostic applications. Its technologies help researchers and healthcare providers analyze biological samples and generate information used in research and patient care.
Recommended Stories
- Five stocks we like better than Revvity
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.
